Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study-Reference-Cited by-同舟云学术

Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study

Published:2018-12-09 Issue: Volume: Page:
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Wei Lai¹,Jia Ji Dong²,Wang Fu Sheng³,Niu Jun Qi⁴,Zhao Xu Min⁵,Mu Shengmei⁵,Liang Li Wen⁵,Wang Zaiqi⁵,Hwang Peggy⁶,Robertson Michael N⁶,Ingravallo Paul⁶,Asante‐Appiah Ernest⁶,Wei Bo⁶,Evans Barbara⁶,Hanna George J⁶,Talwani Rohit⁶,Duan Zhong Ping⁷,Zhdanov Konstantin⁸,Cheng Pin‐Nan⁹,Tanwandee Tawesak¹⁰,Nguyen Van Kinh¹¹,Heo Jeong¹²,Isakov Vasily¹³,George Jacob¹⁴,

Affiliation:

1. Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver DiseasePeking University People's Hospital Beijing China

2. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Cirrhosis, National Clinical Research Center for Digestive DiseasesCapital Medical University Beijing China

3. Treatment and Research Center for Infectious DiseasesBeijing 302 Hospital Beijing China

4. Department of Hepatology, First HospitalJilin University Changchun Jilin China

5. Merck Sharp & DohmeCapital Medical University Beijing China

6. Merck & Co., Inc. Kenilworth New Jersey USA

7. Artificial Liver Center, Beijing YouAn HospitalCapital Medical University Beijing China

8. Military Medical Academy n.a. S.M. Kirov St. Petersburg Russia

9. National Cheng Kung University Tainan Taiwan

10. Department of MedicineFaculty of Medicine Siriraj Hospital Bangkok Thailand

11. National Hospital of Tropical Diseases Hanoi Vietnam

12. College of Medicine, Pusan National University and Medical Research InstitutePusan National University Hospital Busan Republic of Korea

13. Department of Gastroenterology and HepatologyFederal Research Center of Nutrition and Biotechnology Moscow Russia

14. Storr Liver Centre, Westmead Institute for Medical ResearchWestmead Hospital and University of Sydney Westmead New South Wales Australia

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14509

Reference24 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection

2. Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in diagnosis and treatment of hepatitis C;World Chinese Journal of Digestology;2024-07-28

2. Modern principles of etiotropic therapy for chronic hepatitis B and C;Russian Family Doctor;2023-01-18

3. Grazoprevir/Elbasvir treatment in liver or kidney transplant recipients with genotype-1b hepatitis C virus infection;Antimicrobial Agents and Chemotherapy;2021-12-13

4. Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China;Frontiers in Pharmacology;2021-10-15

5. A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection;Frontiers in Pharmacology;2021-09-09